[Ip-health] Re: IGWG II: Limitation on Diseases

Hohman, David E HohmanDE@state.gov
Wed Nov 7 06:44:04 2007


If you don't have access how do you know it's going on?=0D
=0D
-----Original Message-----=0D
From: ip-health-admin@lists.essential.org <ip-health-admin@lists.essential.=
org>=0D
CC: Ip-health@lists.essential.org <Ip-health@lists.essential.org>=0D
Sent: Wed Nov 07 12:31:25 2007=0D
Subject: [Ip-health] Re: IGWG II: Limitation on Diseases=0D
=0D
It seems the footnote 1 may be coming back, they are currently=0D
discussing it in one of the drafting rooms we (NGOS) do not have access to.=
=0D
=0D
Judit Rius Sanjuan wrote:=0D
> We have been informed that yesterday night one of the drafting group=0D
> agreed to eliminate the footnote 1 included in the Secretariat Draft=0D
> Global Strategy and Plan of Action.=0D
>=0D
> These are very good news because the footnote 1 included a=0D
> unjustifiable limitation by listing the diseases that will be the=0D
> focus of this global strategy and plan of action:=0D
>=0D
> Footnote eliminated: "The Commission=E2=80=99s definitions of Type I, Typ=
e II=0D
> and Type III diseases, and the specific diseases on which this draft=0D
> strategy focuses, are as follows: Type I diseases are incident in both=0D
> rich and poor countries, with large numbers of vulnerable populations=0D
> in each. The strategy will focus on the following Type I diseases,=0D
> increasingly prevalent in developing countries: diabetes,=0D
> cardiovascular disease and cancer. Type II diseases are incident in=0D
> both rich and poor countries, but with a substantial proportion of the=0D
> cases in poor countries. For the purposes of the strategy, the focus=0D
> is on HIV/AIDS and tuberculosis. Type III diseases are those that are=0D
> overwhelmingly or exclusively incident in developing countries. For=0D
> the purposes of the strategy, the focus is on the nine neglected=0D
> infectious diseases that disproportionately affect poor and=0D
> marginalized populations prioritized by the UNICEF/UNDP/World Bank/WHO=0D
> Special Programme for Research and Training in Tropical Diseases:=0D
> Chagas disease, dengue and dengue haemorrhagic fever, leishmaniasis,=0D
> leprosy, lymphatic filariasis, malaria, onchocerciasis,=0D
> schistosomiasis and human African trypanosomiasis."=0D
>=0D
=0D
=0D
--=0D
Judit Rius Sanjuan=0D
Attorney=0D
judit.rius@keionline.org=0D
=0D
Knowledge Ecology International (KEI)=0D
www.keionline.org / www.cptech.org=0D
1621 Connecticut Ave, NW, Suite 500 Washington, DC 20009 USA=0D
Tel.: +1.202.332.2670, Ext 18  Fax: +1.202.332.2673=0D
=0D
_______________________________________________=0D
Ip-health mailing list=0D
Ip-health@lists.essential.org=0D
http://lists.essential.org/mailman/listinfo/ip-health=0D